Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: Amedica Corporation

Market Cap 9.11M 7.95M 7.36M 6.89M 12.92M 860M 13M 87.31M 33.84M 423M 34.21M 33.48M 1.47B P/E 2026 *
-0.98x
P/E 2027 * -1.47x
Enterprise Value 9.11M 7.95M 7.36M 6.89M 12.92M 860M 13M 87.31M 33.84M 423M 34.21M 33.48M 1.47B EV / Sales 2026 *
3.96x
EV / Sales 2027 * 1.73x
Free-Float
65.08%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 63 01/12/2007
President - 16/03/2026
Director of Finance/CFO 41 04/09/2025
Director TitleAgeSince
Director/Board Member 63 01/12/2007
Director/Board Member 63 03/04/2025
Director/Board Member 72 05/11/2012
Change 5-day change 1-year change 3-year change Capi.($)
-7.92%-7.29% - - 9.11M
+2.21%-1.41%-18.04%+3.44% 118B
-0.66%-0.71%+4.21%-8.87% 12.63B
+2.57%+3.05%+30.48%+101.32% 7.67B
+0.48%-3.09%-46.72%-71.02% 4.07B
+1.51%+0.28%+19.47%+38.54% 2.55B
+0.94%-1.24%-14.22%-13.08% 1.77B
-0.21%-4.06%+4.27%-20.44% 1.59B
+5.36%+9.88%+189.38%+152.24% 1.49B
Average +0.48%+0.99%+21.11%+22.77% 18.72B
Weighted average by Cap. +1.92%+0.74%-11.48%+7.02%

Financials

2026 *2027 *
Net sales 2.3M 2.01M 1.86M 1.74M 3.27M 217M 3.29M 22.07M 8.55M 107M 8.65M 8.46M 371M 5.27M 4.59M 4.25M 3.98M 7.47M 497M 7.51M 50.46M 19.56M 245M 19.77M 19.35M 849M
Net income -12.38M -10.79M -10M -9.36M -17.55M -1.17B -17.66M -119M -45.96M -575M -46.47M -45.47M -2B -11.38M -9.92M -9.19M -8.6M -16.13M -1.07B -16.23M -109M -42.24M -528M -42.7M -41.79M -1.83B
Net Debt - -
Logo Amedica Corporation
SINTX Technologies, Inc. is an advanced ceramics company that develops and commercializes materials, components, and technologies for medical and agribiotech applications. It is engaged in the research, development, and manufacturing of silicon nitride. Its core business includes biomedical applications and antipathogenic applications. It has been focused on medical grade silicon nitride. Spinal implants made from its silicon nitride have been implanted in humans. This established use, along with its inherent resistance to bacterial adhesion and bone affinity suggests that it may also be suitable in other fusion device applications such as arthroplasty implants, foot wedges, and dental implants. Its composition of silicon nitride antipathogenic powder may enable manufacturing surfaces that inactivate pathogens, thereby limiting the spread of infection and disease. It manufactures advanced ceramic powders and components in its manufacturing facilities based in Salt Lake City, Utah.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!